These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 27505446)
1. Novel mouse model for primary uveal melanoma: a pilot study. Süsskind D; Hurst J; Rohrbach JM; Schnichels S Clin Exp Ophthalmol; 2017 Mar; 45(2):192-200. PubMed ID: 27505446 [TBL] [Abstract][Full Text] [Related]
2. Intravitreally Injected HCmel12 Melanoma Cells Serve as a Mouse Model of Tumor Biology of Intraocular Melanoma. Kilian MM; Loeffler KU; Pfarrer C; Holz FG; Kurts C; Herwig MC Curr Eye Res; 2016; 41(1):121-8. PubMed ID: 25658144 [TBL] [Abstract][Full Text] [Related]
3. Expression and distribution of MMPs and TIMPs in human uveal melanoma. Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620 [TBL] [Abstract][Full Text] [Related]
4. Characterisation of novel uveal melanoma cell lines under serum-free conditions. Suesskind D; Gauss S; Faust UE; Bauer P; Schrader M; Bartz-Schmidt KU; Henke-Fahle S Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2063-70. PubMed ID: 23456173 [TBL] [Abstract][Full Text] [Related]
5. Tumor cell plasticity in uveal melanoma: microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns. Folberg R; Arbieva Z; Moses J; Hayee A; Sandal T; Kadkol S; Lin AY; Valyi-Nagy K; Setty S; Leach L; Chévez-Barrios P; Larsen P; Majumdar D; Pe'er J; Maniotis AJ Am J Pathol; 2006 Oct; 169(4):1376-89. PubMed ID: 17003493 [TBL] [Abstract][Full Text] [Related]
6. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma. Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731 [TBL] [Abstract][Full Text] [Related]
7. Modeling the behavior of uveal melanoma in the liver. Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861 [TBL] [Abstract][Full Text] [Related]
8. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306 [TBL] [Abstract][Full Text] [Related]
9. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas. Onken MD; Lin AY; Worley LA; Folberg R; Harbour JW Am J Ophthalmol; 2005 Oct; 140(4):748-9. PubMed ID: 16226537 [TBL] [Abstract][Full Text] [Related]
10. Microvascular loops and networks in uveal melanoma. Kivelä T; Mäkitie T; Al-Jamal RT; Toivonen P Can J Ophthalmol; 2004 Jun; 39(4):409-21. PubMed ID: 15327107 [TBL] [Abstract][Full Text] [Related]
11. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread? Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000 [TBL] [Abstract][Full Text] [Related]
12. An orthotopic model for human uveal melanoma in SCID mice. Mueller AJ; Maniotis AJ; Freeman WR; Bartsch DU; Schaller UC; Bergeron-Lynn G; Cheng L; Taskintuna I; Chen X; Kan-Mitchell J; Folberg R Microvasc Res; 2002 Sep; 64(2):207-13. PubMed ID: 12204644 [TBL] [Abstract][Full Text] [Related]
13. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma. Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494 [TBL] [Abstract][Full Text] [Related]
14. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Maniotis AJ; Folberg R; Hess A; Seftor EA; Gardner LM; Pe'er J; Trent JM; Meltzer PS; Hendrix MJ Am J Pathol; 1999 Sep; 155(3):739-52. PubMed ID: 10487832 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the typical multidrug resistance profile in human uveal melanoma cell lines and in mouse liver metastasis derivatives. Labialle S; Dayan G; Gambrelle J; Gayet L; Barakat S; Devouassoux-Shisheboran M; Bernaud J; Rigal D; Grange JD; Baggetto LG Melanoma Res; 2005 Aug; 15(4):257-66. PubMed ID: 16034303 [TBL] [Abstract][Full Text] [Related]
16. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Shah AA; Bourne TD; Murali R Pathology; 2013 Dec; 45(7):651-6. PubMed ID: 24247622 [TBL] [Abstract][Full Text] [Related]
17. Effects of Long-term Serial Passaging on the Characteristics and Properties of Cell Lines Derived From Uveal Melanoma Primary Tumors. Mouriaux F; Zaniolo K; Bergeron MA; Weidmann C; De La Fouchardière A; Fournier F; Droit A; Morcos MW; Landreville S; Guérin SL Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5288-5301. PubMed ID: 27723895 [TBL] [Abstract][Full Text] [Related]